title: Should persons with autosomal dominant AD be included in clinical trials?
authors: Department of Neurology, Mary S, Easton Center for Alzheimer's Disease Research, David Geffen School of Medicine at UCLA, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90095-07226, USA. jgrill@mednet.ucla.edu.
authors: Joshua D
authors: JD
authors: Grill
authors: John M
authors: JM
authors: Ringman
references: Neurobiol Dis. 2008 Sep;31(3):442-50
references: 18602473
references: Alzheimers Res Ther. 2011 Jan 06;3(1):1
references: 21211070
references: Alzheimers Res Ther. 2011 Feb 08;3(1):4
references: 21345175
references: J Biol Chem. 2007 Aug 24;282(34):24504-13
references: 17573346
references: Lancet. 2003 Jun 7;361(9373):1957-8
references: 12801742
references: J Neurochem. 2011 Feb;116(3):385-95
references: 21091478
references: EMBO Rep. 2007 Feb;8(2):141-6
references: 17268505